The Claim
Administering oral melatonin doses exceeding standard amounts (2 mg and 4 mg) may be necessary to saturate first-pass metabolic pathways, thereby increasing systemic bioavailability and partially overcoming the low bioavailability inherent to standard oral melatonin formulations.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking a higher dose of melatonin might help more of the supplement actually get into your bloodstream. This happens because larger amounts can overwhelm the liver's natural breakdown process, making the supplement more effective than standard low doses.
See the scientific wording
Administering higher oral doses of melatonin beyond standard 2 mg and 4 mg amounts may be required to potentially saturate first-pass metabolic pathways, thereby increasing the proportion of the drug that reaches systemic circulation. This pharmacokinetic principle suggests that dose escalation could partially overcome the inherent low bioavailability of oral melatonin formulations.
What the research says
1 studyStudy: The Absolute Bioavailability of Oral Melatonin
The study shows that standard low doses of melatonin are mostly broken down by the liver before entering the bloodstream, which supports the idea that taking higher doses might help more of the drug reach the body.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.